html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 8 Catechol-O-methyltransferase inhibitors in the management of Parkinson’s disease Ilana Schlesinger and Amos D. Korczyn The introduction of 3,4-dihydroxyphenylalanine (DOPA) to the treatment of Parkinson’s…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 5 Oral dopamine agonists in the management of Parkinson’s disease Javier Pagonabarraga, Juan Marín-Lahoz and Jaime Kulisevsky Introduction and history In 1960 and 1967, Hornykiewicz…
Figure 2.1 Prescription of anticholinergic treatment used by Professor Charcot, dated 1887 from the College of Physicians of Philadelphia Library. The cholinergic system and Parkinson’s disease Some authors have postulated…
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 4 Monoamine oxidase inhibitors in the management of Parkinson’s disease Sven-Eric Pålhagen Introduction Monoamine oxidase B (MAO-B) inhibitors have again become relevant as a good…
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
, Damien Gervasoni1 and Catherine Vogt2 (1) Lyon Neuroscience Research Centre CNRS UMR 5292–INSERM U 1028, Université Claude Bernard Lyon 1, Lyon, France (2) Université Claude Bernard Lyon 1, Lyon, France …
